BusinessProQR Announces the Grant of two Key Patents, protecting QR-010 for Cystic Fibrosis in the US and EUBy Nasdaq OMXApr 3, 2017, 11:02 AM UTC
BusinessProQR Appoints David M. Rodman, MD as Chief Development Strategy OfficerBy Nasdaq OMXMar 27, 2017, 11:02 AM UTC
BusinessProQR Announces Results for the Fourth Quarter and Full Year 2016 and Provides a Business UpdateBy Nasdaq OMXFeb 28, 2017, 12:01 PM UTC
BusinessProQR Announces Results for the Fourth Quarter and Full Year 2016 and Provides a Business UpdateBy Nasdaq OMXFeb 28, 2017, 12:01 PM UTC
BusinessOn a Shared Quest to Find Treatments for Rare Diseases, ProQR Supports Rare Disease DayBy Nasdaq OMXFeb 27, 2017, 12:01 PM UTC
BusinessOn a Shared Quest to Find Treatments for Rare Diseases, ProQR Supports Rare Disease DayBy Nasdaq OMXFeb 27, 2017, 12:01 PM UTC
